Global H5N1 Influenza Disease Treatment Market, By Treatment (Antibiotics, Antiviral Agents, Vaccines, Immunoglobulins), Drug Type (Antivirals, Neuraminidase Inhibitors, Ion channelM2 Blockers, Combination Treatment, Prophylactic Antibiotics, Steroids and Other Immunosuppressants, Immunoglobulin, Ribavirin, Others), Symptoms (High Fever, Cough, Diarrhea, Headache, Sore Throat, Runny Nose, Muscle Ache), Distribution Channel (Institutional Health Centers, Hospital Pharmacies, Clinics, Online Pharmacies), End Users (Hospital, Institutional Health Centers, Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028